Progenitor cell therapy to treat acute myocardial infarction: The promise of high-dose autologous CD34+ bone marrow mononuclear cells

Stem Cells International

Volumn , Issue , 2013, Pages

  Poole, Joseph C ^a   Quyyumi, Arshed A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMR 001; CARDIOVASCULAR AGENT; CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; STROMAL CELL DERIVED FACTOR 1; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 2;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW CELL; CELL LOSS; CELL MIGRATION; CELL REGENERATION; CELL TYPE; CELL VIABILITY; CORONARY ARTERY DISEASE; DRUG DOSE ESCALATION; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MONONUCLEAR CELL; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PURIFICATION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STEM CELL TRANSPLANTATION;

EID: 84878285209     PISSN: None     EISSN: 16879678     Source Type: Journal    
DOI: 10.1155/2013/658480     Document Type: Review

References (56)

1. Brodie B. R., Stuckey T. D., Hansen C. J., Muncy D. B., Weintraub R. A., Kelly T. A., Berry J. J., Timing and mechanism of death determined clinically after primary angioplasty for acute myocardial infarction. American Journal of Cardiology 1997 79 12 1586 1591 2-s2.0-0030837998 10.1016/S0002-9149(97)00203-8
2. Busk M., Maeng M., Kristensen S. D., Thuesen L., Krusell L. R., Mortensen L. S., Steinmetz E. R., Nielsen T. T., Andersen H. R., Timing, causes, and predictors of death after three years' follow-up in the danish multicenter randomized study of fibrinolysis versus primary angioplasty in acute myocardial infarction (DANAMI-2) trial. American Journal of Cardiology 2009 104 2 210 215 2-s2.0-67649372664 10.1016/j.amjcard.2009.03.014
3. Abbate A., Bussani R., Biondi-Zoccai G. G. L., Santini D., Petrolini A., De Giorgio F., Vasaturo F., Scarpa S., Severino A., Liuzzo G., Leone A. M., Baldi F., Sinagra G., Silvestri F., Vetrovec G. W., Crea F., Biasucci L. M., Baldi A., Infarct-related artery occlusion, tissue markers of ischaemia, and increased apoptosis in the peri-infarct viable myocardium. European Heart Journal 2005 26 19 2039 2045 2-s2.0-26444589165 10.1093/eurheartj/ehi419
4. Angeja B. G., Gunda M., Murphy S. A., Sobel B. E., Rundle A. C., Syed M., Asfour A., Borzak S., Gourlay S. G., Barron H. V., Gibbons R. J., Gibson C. M., TIMI myocardial perfusion grade and ST segment resolution: association with infarct size as assessed by single photon emission computed tomography imaging. Circulation 2002 105 3 282 285 2-s2.0-0037154322 10.1161/hc0302.103588
5. Pfeffer M. A., McMurray J. J. V., Velazquez E. J., Rouleau J. L., Køber L., Maggioni A. P., Solomon S. D., Swedberg K., van de Werf F., White H., Leimberger J. D., Henis M., Edwards S., Zelenkofske S., Sellers M. A., Califf R. M., Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. The New England Journal of Medicine 2003 349 20 1893 1906 2-s2.0-0242490542 10.1056/NEJMoa032292
6. Strauer B. E., Brehm M., Zeus T., Köstering M., Hernandez A., Sorg R. V., Kögler G., Wernet P., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 2002 106 15 1913 1918 2-s2.0-0037044406 10.1161/01.CIR.0000034046. 87607.1C
7. Abdel-Latif A., Bolli R., Tleyjeh I. M., Montori V. M., Perin E. C., Hornung C. A., Zuba-Surma E. K., Al-Mallah M., Dawn B., Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Archives of Internal Medicine 2007 167 10 989 997 2-s2.0-33947305414 10.1001/archinte.167.10.989
8. Lipinski M. J., Biondi-Zoccai G. G. L., Abbate A., Khianey R., Sheiban I., Bartunek J., Vanderheyden M., Kim H. S., Kang H. J., Strauer B. E., Vetrovec G. W., Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction. A collaborative systematic review and meta-analysis of controlled clinical trials. Journal of the American College of Cardiology 2007 50 18 1761 1767 2-s2.0-35349008966 10.1016/j.jacc.2007.07.041
9. Martin-Rendon E., Brunskill S. J., Hyde C. J., Stanworth S. J., Mathur A., Watt S. M., Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. European Heart Journal 2008 29 15 1807 1818 2-s2.0-48749100385 10.1093/eurheartj/ehn220
10. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., Grünwald F., Aicher A., Urbich C., Martin H., Hoelzer D., Dimmeler S., Zeiher A. M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 2002 106 24 3009 3017 2-s2.0-0037058848 10.1161/01.CIR.0000043246.74879.CD
11. Schächinger V., Assmus B., Britten M. B., Honold J., Lehmann R., Teupe C., Abolmaali N. D., Vogl T. J., Hofmann W. K., Martin H., Dimmeler S., Zeiher A. M., Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. Journal of the American College of Cardiology 2004 44 8 1690 1699 2-s2.0-5644236574 10.1016/j.jacc.2004.08.014
12. Leistner D. M., Fischer-Rasokat U., Honold J.,. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI): final 5-year results suggest long-term safety and efficacy. Clinical Research in Cardiology 2011 100 925 934 10.1007/s00392-011-0327-y
13. Wollert K. C., Meyer G. P., Lotz J., Ringes-Lichtenberg S., Lippolt P., Breidenbach C., Fichtner S., Korte T., Hornig B., Messinger D., Arseniev L., Hertenstein B., Ganser A., Drexler H., Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial. The Lancet 2004 364 9429 141 148 2-s2.0-3042710733 10.1016/S0140-6736(04) 16626-9
14. Meyer G. P., Wollert K. C., Lotz J., Pirr J., Rager U., Lippolt P., Hahn A., Fichtner S., Schaefer A., Arseniev L., Ganser A., Drexler H., Intracoronary bone marrow cell transfer after myocardial infarction: 5-year follow-up from the randomized-controlled BOOST trial. European Heart Journal 2009 30 24 2978 2984 2-s2.0-72649085884 10.1093/eurheartj/ehp374
15. Ge J., Li Y., Qian J., Shi J., Wang Q., Niu Y., Fan B., Liu X., Zhang S., Sun A., Zou Y., Efficacy of emergent transcatheter transplantation of stem cells for treatment of acute myocardial infarction (TCT-STAMI). Heart 2006 92 12 1764 1767 2-s2.0-33750008487 10.1136/hrt.2005.085431
16. Huikuri H. V., Kervinen K., Niemelä M., Ylitalo K., Säily M., Koistinen P., Savolainen E. R., Ukkonen H., Pietilä M., Airaksinen J. K. E., Knuuti J., Mäkikallio T. H., Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction. European Heart Journal 2008 29 22 2723 2732 2-s2.0-56449121207 10.1093/eurheartj/ehn436
17. Schachinger V., Erbs S., Elsasser A., Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. The New England Journal of Medicine 2006 355 1210 1221 10.1056/NEJMoa060186
18. Assmus B., Rolf A., Erbs S., Elsässer A., Haberbosch W., Hambrecht R., Tillmanns H., Yu J., Corti R., Mathey D. G., Hamm C. W., Süselbeck T., Tonn T., Dimmeler S., Dill T., Zeiher A. M., Schächinger V., Clinical outcome 2 years after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction. Circulation 2010 3 1 89 96 2-s2.0-76549111138 10.1161/CIRCHEARTFAILURE.108.843243
19. Hirsch A., Nijveldt R., van der Vleuten P. A., Tijssen J. G. P., van der Giessen W. J., Tio R. A., Waltenberger J., Ten Berg J. M., Doevendans P. A., Aengevaeren W. R. M., Zwaginga J. J., Biemond B. J., van Rossum A. C., Piek J. J., Zijlstra F., Intracoronary infusion of mononuclear cells from bone marrow or peripheral blood compared with standard therapy in patients after acute myocardial infarction treated by primary percutaneous coronary intervention: results of the randomized controlled HEBE trial. European Heart Journal 2011 32 14 1736 1747 2-s2.0-79960475582 10.1093/eurheartj/ehq449
20. Janssens S., Dubois C., Bogaert J., Theunissen K., Deroose C., Desmet W., Kalantzi M., Herbots L., Sinnaeve P., Dens J., Maertens J., Rademakers F., Dymarkowski S., Gheysens O., van Cleemput J., Bormans G., Nuyts J., Belmans A., Mortelmans L., Boogaerts M., van de Werf F., Autologous bone marrow-derived stem-cell transfer in patients with ST-segment elevation myocardial infarction: double-blind, randomised controlled trial. The Lancet 2006 367 9505 113 121 2-s2.0-30444432961 10.1016/S0140-6736(05)67861-0
21. Lunde K., Solheim S., Aakhus S., Arnesen H., Abdelnoor M., Egeland T., Endresen K., Ilebekk A., Mangschau A., Fjeld J. G., Smith H. J., Taraldsrud E., Grøgaard H. K., Bjørnerheim R., Brekke M., Müller C., Hopp E., Ragnarsson A., Brinchmann J. E., Forfang K., Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. The New England Journal of Medicine 2006 355 12 1199 1209 2-s2.0-33748899627 10.1056/NEJMoa055706
22. Traverse J. H., Henry T. D., Ellis S. G., Effect of intracoronary delivery of autologous bone marrow mononuclear cells 2 to 3 weeks following acute myocardial infarction on left ventricular function: the LateTIME randomized trial. Journal of the American Medical Association 2011 306 2110 2119 10.1001/jama.2011.1670
23. Traverse J. H., McKenna D. H., Harvey K., Jorgenso B. C., Olson R. E., Bostrom N., Kadidlo D., Lesser J. R., Jagadeesan V., Garberich R., Henry T. D., Results of a phase 1, randomized, double-blind, placebo-controlled trial of bone marrow mononuclear stem cell administration in patients following ST-elevation myocardial infarction. American Heart Journal 2010 160 3 428 434 2-s2.0-77956364230 10.1016/j.ahj.2010.06.009
24. Miettinen J. A., Ylitalo K., Hedberg P., Jokelainen J., Kervinen K., Niemelä M., Säily M., Koistinen P., Savolainen E. R., Ukkonen H., Pietilä M., Juhani Airaksinen K. E., Knuuti J., Vuolteenaho O., Mäkikallio T. H., Huikuri H. V., Determinants of functional recovery after myocardial infarction of patients treated with bone marrow-derived stem cells after thrombolytic therapy. Heart 2010 96 5 362 367 2-s2.0-77649195344 10.1136/hrt.2009.171694
25. + cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. European Heart Journal 2009 30 11 1313 1321 2-s2.0-67649657795 10.1093/eurheartj/ehp073
26. Fermas S., Gonnet F., Sutton A., Charnaux N., Mulloy B., Du Y., Baleux F., Daniel R., Sulfated oligosaccharides (heparin and fucoidan) binding and dimerization of stromal cell-derived factor-1 (SDF-1/CXCL 12) are coupled as evidenced by affinity CE-MS analysis. Glycobiology 2008 18 12 1054 1064 2-s2.0-57049126122 10.1093/glycob/cwn088
27. Hofmann M., Wollert K. C., Meyer G. P., Menke A., Arseniev L., Hertenstein B., Ganser A., Knapp W. H., Drexler H., Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 2005 111 17 2198 2202 2-s2.0-18244401368 10.1161/01.CIR.0000163546.27639.AA
28. + hematopoietic progenitor cells in a rat myocardial infarction model. Journal of Nuclear Medicine 2004 45 3 512 518 2-s2.0-2342474520
29. Britten M. B., Abolmaali N. D., Assmus B., Lehmann R., Honold J., Schmitt J., Vogl T. J., Martin H., Schächinger V., Dimmeler S., Zeiher A. M., Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging. Circulation 2003 108 18 2212 2218 2-s2.0-0242637112 10.1161/01.CIR.0000095788.78169.AF
30. Kawamoto A., Iwasaki H., Kusano K., Murayama T., Oyamada A., Silver M., Hulbert C., Gavin M., Hanley A., Ma H., Kearney M., Zak V., Asahara T., Losordo D. W., CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 2006 114 20 2163 2169 2-s2.0-33750991077 10.1161/ CIRCULATIONAHA.106.644518
31. Seeger F. H., Tonn T., Krzossok N., Zeiher A. M., Dimmeler S., Cell isolation procedures matter: a comparison of different isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. European Heart Journal 2007 28 6 766 772 2-s2.0-33947310406 10.1093/eurheartj/ehl509
32. Miraglia S., Godfrey W., Yin A. H., Atkins K., Warnke R., Holden J. T., Bray R. A., Waller E. K., Buck D. W., A novel five-transmembrane hematopoietic stem cell antigen: isolation, characterization, and molecular cloning. Blood 1997 90 12 5013 5021 2-s2.0-0031468289
33. Yin A. H., Miraglia S., Zanjani E. D., Almeida-Porada G., Ogawa M., Leary A. G., Olweus J., Kearney J., Buck D. W., AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997 90 12 5002 5012 2-s2.0-0031453534
34. Guo S., Cheng Y., Ma Y., Yang X., Endothelial progenitor cells derived from CD34 cells form cooperative vascular networks. Cellular Physiology and Biochemistry 2010 26 4-5 679 688 2-s2.0-78149456608 10.1159/000322335
35. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J. M., Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997 275 5302 964 967 2-s2.0-0031019745 10.1126/science.275.5302.964
36. +-enriched cell population Into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 2003 108 17 2070 2073 2-s2.0-0242318367 10.1161/01.CIR.0000099501.52718.70
37. + cells identifies a population of functional endothelial precursors. Blood 2000 95 3 952 958 2-s2.0-12944253116
38. Stamm C., Westphal B., Kleine H. D., Petzsch M., Kittner C., Klinge H., Schümichen C., Nienaber C. A., Freund M., Steinhoff G., Autologous bone-marrow stem-cell transplantation for myocardial regeneration. The Lancet 2003 361 9351 45 46 2-s2.0-0037417501 10.1016/S0140-6736(03)12110-1
39. + cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent. American Heart Journal 2011 161 1 98 105 2-s2.0-78650279845 10.1016/j.ahj.2010.09.025
40. Jo D. Y., Rafii S., Hamada T., Moore M. A. S., Chemotaxis of primitive hematopoietic cells in response to stromal cell-derived factor-1. Journal of Clinical Investigation 2000 105 1 101 111 2-s2.0-0033989027
41. Garcia E. V., Faber T. L., Cooke C. D., Folks R. D., Chen J., Santana C., The increasing role of quantification in clinical nuclear cardiology: the Emory approach. Journal of Nuclear Cardiology 2007 14 4 420 432 2-s2.0-34547414604 10.1016/j.nuclcard.2007.06.009
42. Gyöngyösi M., Lang I., Dettke M., Beran G., Graf S., Sochor H., Nyolczas N., Charwat S., Hemetsberger R., Christ G., Édes I., Balogh L., Krause K. T., Jaquet K., Kuck K. H., Benedek I., Hintea T., Kiss R., Préda I., Kotevski V., Pejkov H., Zamini S., Khorsand A., Sodeck G., Kaider A., Maurer G., Glogar D., Combined delivery approach of bone marrow mononuclear stem cells early and late after myocardial infarction: the MYSTAR prospective, randomized study. Nature Clinical Practice Cardiovascular Medicine 2009 6 1 70 81 2-s2.0-58049192920 10.1038/ncpcardio1388
43. Spinelli L., Petretta M., Acampa W., He W., Petretta A., Bonaduce D., Cuocolo A., Prognostic value of combined assessment of regional left ventricular function and myocardial perfusion by dobutamine and rest gated SPECT in patients with uncomplicated acute myocardial infarction. Journal of Nuclear Medicine 2003 44 7 1023 1029 2-s2.0-0041386246
44. Bondarenko O., Beek A. M., Twisk J. W. R., Visser C. A., van Rossum A. C., Time course of functional recovery after revascularization of hibernating myocardium: a contrast-enhanced cardiovascular magnetic resonance study. European Heart Journal 2008 29 16 2000 2005 2-s2.0-49749102731 10.1093/eurheartj/ehn266
45. Yan L., Vatner D. E., Kim S. J., Ge H., Masurekar M., Massover W. H., Yang G., Matsui Y., Sadoshima J., Vatner S. F., Autophagy in chronically ischemic myocardium. Proceedings of the National Academy of Sciences of the United States of America 2005 102 39 13807 13812 2-s2.0-25444473426 10.1073/pnas.0506843102
46. Fernandez-Aviles F., San Roman J. A., Garcia-Frade J., Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circulation Research 2004 95 742 748 10.1161/01.RES.0000144798. 54040.ed
47. Meyer G. P., Wollert K. C., Lotz J., Steffens J., Lippolt P., Fichtner S., Hecker H., Schaefer A., Arseniev L., Hertenstein B., Ganser A., Drexler H., Intracoronary bone marrow cell transfer after myocardial infarction: eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 2006 113 10 1287 1294 2-s2.0-33645743539 10.1161/CIRCULATIONAHA.105.575118
48. Uemura R., Xu M., Ahmad N., Ashraf M., Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circulation Research 2006 98 11 1414 1421 2-s2.0-33745356932 10.1161/01.RES.0000225952.61196.39
49. Dimmeler S., Burchfield J., Zeiher A. M., Cell-based therapy of myocardial infarction. Arteriosclerosis, Thrombosis, and Vascular Biology 2008 28 2 208 216 2-s2.0-38549163419 10.1161/ATVBAHA.107.155317
50. Meluzín J., Janoušek S., Mayer J., Groch L., Horňáček I., Hlinomaz O., Kala P., Panovský R., Prášek J., Kamínek M., Staníček J., Klabusay M., Kořístek Z., Navrátil M., Dušek L., Vinklárková J., Three-, 6-, and 12-month results of autologous transplantation of mononuclear bone marrow cells in patients with acute myocardial infarction. International Journal of Cardiology 2008 128 2 185 192 2-s2.0-47349104151 10.1016/j.ijcard.2007.04.098
51. Leone A. M., Rutella S., Bonanno G., Abbate A., Rebuzzi A. G., Giovannini S., Lombardi M., Galiuto L., Liuzzo G., Andreotti F., Lanza G. A., Contemi A. M., Leone G., Crea F., Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function. European Heart Journal 2005 26 12 1196 1204 2-s2.0-20844442611 10.1093/eurheartj/ehi164
52. Cao F., Sun D., Li C., Narsinh K., Zhao L., Li X., Feng X., Zhang J., Duan Y., Wang J., Liu D., Wang H., Long-term myocardial functional improvement after autologous bone marrow mononuclear cells transplantation in patients with ST-segment elevation myocardial infarction: 4 years follow-up. European Heart Journal 2009 30 16 1986 1994 2-s2.0-68949162209 10.1093/eurheartj/ehp220
53. Brunskill S. J., Hyde C. J., Doree C. J., Watt S. M., Martin-Rendon E., Route of delivery and baseline left ventricular ejection fraction, key factors of bone-marrow-derived cell therapy for ischaemic heart disease. European Journal of Heart Failure 2009 11 9 887 896 2-s2.0-69249132425 10.1093/eurjhf/hfp101
54. Yao K., Huang R., Sun A., Qian J., Liu X., Ge L., Zhang Y., Zhang S., Niu Y., Wang Q., Zou Y., Ge J., Repeated autologous bone marrow mononuclear cell therapy in patients with large myocardial infarction. European Journal of Heart Failure 2009 11 7 691 698 2-s2.0-67650085037 10.1093/eurjhf/hfp062
55. Bartunek J., Vanderheyden M., Vandekerckhove B., Mansour S., De Bruyne B., De Bondt P., van Haute I., Lootens N., Heyndrickx G., Wijns W., Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 2005 112 9 I178 I183 2-s2.0-24644474680 10.1161/ CIRCULATIONAHA.104.522292
56. Roncalli J., Mouquet F., Piot C., Trochu J. N., Le Corvoisier P., Neuder Y., le Tourneau T., Agostini D., Gaxotte V., Sportouch C., Galinier M., Crochet D., Teiger E., Richard M. J., Polge A. S., Beregi J. P., Manrique A., Carrie D., Susen S., Klein B., Parini A., Lamirault G., Croisille P., Rouard H., Bourin P., Nguyen J. M., Delasalle B., Vanzetto G., van Belle E., Lemarchand P., Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: Results of the randomized multicenter BONAMI trial. European Heart Journal 2011 32 14 1748 1757 2-s2.0-79960541758 10.1093/eurheartj/ehq455